Literature DB >> 886648

Carbohydrates of influenza virus. I. Glycopeptides derived from viral glycoproteins after labeling with radioactive sugars.

R T Schwarz, M F Schmidt, U Anwer, H D Klenk.   

Abstract

The carbohydrate moiety of the influenza glycoproteins NA, HA(1), and HA(2) were analyzed by labeling with radioactive sugars. Analysis of glycopeptides obtained after digestion with Pronase indicated that there are at least two different types of carbohydrate side chains. The side chain of type I is composed of glucosamine, mannose, galactose, and fucose. It is found on NA, HA(1), and HA(2). The side chain of type II contains a high amount of mannose and is found only on NA and HA(2). The molecular weights of the corresponding glycopeptides obtained from virus grown in chicken embryo cells are 2,600 for type I and 2,000 for type II. The glycoproteins of virus grown in MDBK cells have a higher molecular weight than those of virus grown in chicken embryo cells, and there is a corresponding difference in the molecular weights of the glycopeptides. Under conditions of partial inhibition of glycosylation, virus particles were isolated that contained hemagglutinin with reduced carbohydrate content. Glycopeptide analysis indicated that this reduction is due to the lack of whole carbohydrate side chains and not to the incorporation of incomplete ones. This observation suggests that glycosylation of the viral glycoproteins involves en bloc transfer of the core sugars to the polypeptide chains.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 886648      PMCID: PMC515823     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  THE CARBOHYDRATE UNITS OF THYROGLOBULIN.

Authors:  R G SPIRO
Journal:  J Biol Chem       Date:  1965-04       Impact factor: 5.157

2.  Effect of 2-deoxy-D-glucose on the multiplication of Semliki Forest virus and the reversal of the block by mannose.

Authors:  G Kaluza; M F Schmidt; C Scholtissek
Journal:  Virology       Date:  1973-07       Impact factor: 3.616

3.  Association of influenza virus proteins with cytoplasmic fractions.

Authors:  H D Klenk; W Wöllert; R Rott; C Scholtissek
Journal:  Virology       Date:  1974-01       Impact factor: 3.616

4.  Interference of nucleoside diphosphate derivatives of 2-deoxy-D-glucose with the glycosylation of virus-specific glycoproteins in vivo.

Authors:  M F Schmidt; R T Schwarz; C Scholtissek
Journal:  Eur J Biochem       Date:  1976-11-01

5.  The specific site of tunicamycin inhibition in the formation of dolichol-bound N-acetylglucosamine derivatives.

Authors:  L Lehle; W Tanner
Journal:  FEBS Lett       Date:  1976-11-15       Impact factor: 4.124

6.  Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins.

Authors:  R W Compans; H D Klenk; L A Caliguiri; P W Choppin
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

7.  Formation of dolichol monophosphate 2-deoxy-D-glucose and its interference with the glycosylation of mannoproteins in yeast.

Authors:  L Lehle; R T Schwarz
Journal:  Eur J Biochem       Date:  1976-08-01

8.  Physical and biological properties of influenza virus components obtained after ether treatment.

Authors:  F M DAVENPORT; R ROTT; W SCHAEFER
Journal:  J Exp Med       Date:  1960-11-01       Impact factor: 14.307

9.  [Complete structure of glycopeptides isolated from IgG immunoglobulins of cow colostrum].

Authors:  A Chéron; B Fournet; G Spik; J Montreuil
Journal:  Biochimie       Date:  1976       Impact factor: 4.079

10.  Suppression of glycoprotein formation of Semliki Forest, influenza, and avian sarcoma virus by tunicamycin.

Authors:  R T Schwarz; J M Rohrschneider; M F Schmidt
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

View more
  24 in total

1.  The carbohydrates of influenza virus. II. Gas chromatographic analysis of glycopeptides derived from viral glycoproteins and mucopolysaccharides.

Authors:  R T Schwarz; B Fournet; J Montreuil; R Rott; H D Klenk
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

2.  Structural analysis of precursor and product forms of type-common envelope glycoprotein D (CP-1 antigen) of herpes simplex virus type 1.

Authors:  R J Eisenberg; C Hydrean-Stern; G H Cohen
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

3.  Possible requirement of collagen gel substratum for production of mucin-like glycoproteins by primary rabbit tracheal epithelial cells in culture.

Authors:  K C Kim
Journal:  In Vitro Cell Dev Biol       Date:  1985-11

4.  The role of carbohydrate in determining the immunochemical properties of the hemagglutinin of influenza A virus.

Authors:  A K Gitelman; V A Berezin; I G Kharitonenkov
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

5.  The structural basis of the function of influenza virus glycoproteins.

Authors:  R Rott
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

6.  Evidence for covalent attachment of fatty acids to Sindbis virus glycoproteins.

Authors:  M F Schmidt; M Bracha; M J Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

7.  Interference with glycosylation of glycoproteins. Inhibition of formation of lipid-linked oligosaccharides in vivo.

Authors:  R Datema; R T Schwarz
Journal:  Biochem J       Date:  1979-10-15       Impact factor: 3.857

8.  Influenza virus hemagglutinin containing an altered hydrophobic carboxy terminus accumulates intracellularly.

Authors:  M M Sveda; L J Markoff; C J Lai
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

9.  Intracellular glycosylation of influenza hemagglutinin: the effect of glucosamine.

Authors:  M A Horisberger; C de Staritzky; J Content
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

10.  Carbohydrate components of influenza C virions.

Authors:  K Nakamura; G Herrler; T Petri; H Meier-Ewert; R W Compans
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.